SmithKline's former top executive, Jean-Pierre Garnier, who was Glaxo's CEO until last month, said in a 2006 deposition in a lawsuit that the original data given to the FDA shouldn't have included some of the placebo patients.

In testimony to the House in 2007, Dr. Buse said he was characterized as a "liar" and threatened with a lawsuit if SmithKline's stock dropped because of his statements about Avandia's possible dangers.

The vaccines currently available, like Merck's Gardasil and Glaxo SmithKline's Cervarix, have only been tested for their effectiveness against the viruses that lead to cervical, vulvar and anal cancers.

They didn't have to face the fact that they were also hurting American industry by removing an inexpensive raw material for making (at the time) textiles, paper, vegetable oil, fuel, and pharmaceutical drugs (like SmithKline's "American Cannabis" tincture) out of the supply chain.

Sept. 28, 2005) (pdf), a long opinion approving a class action settlement (with a consumer component based on consumer loss due to SmithKline's patent activities that increased the price of Relafen, a non-steroidal anti-inflammatory drug) but with an appendix decrying the rise of settlements and the corresponding demise of the jury trial.